For several weeks, it looked like the former South Dakota State star was going to have to find a new NFL home. Even while ...

Having to take Ozempic or other weight loss drugs can be a real pain in the ass, with users often having to jab themselves ...

Amgen aims to challenge obesity drug leaders with MariTide, a potential monthly treatment now in late-stage trials.

A NEW weight loss jab that only needs to be taken once monthly leads to “substantial weight loss”, according to early trials.

A 333-unit community, Hillcrest Apartments, will be developed directly across from Amgen’s headquarters in Thousand Oaks, ...

Invesco LLC slashed its Amgen holdings by 20.2%, unloading 2,310 shares worth roughly $2.85 million. This sale brought ...

In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...

What does the fracturing of vaccine advice and policy mean for the U.S. health care ecosystem? Will the potential head of the Centers for Disease Control ...

JLL Capital Markets secured $182M in construction financing & equity for Latigo Group's 333-unit Hillcrest Apartments in ...

Artificial intelligence chatbots are fast becoming staples of modern office life, but it’s clear that not all tools are ...

Despite investing tens of billions of dollars into OpenAI, Microsoft is still, apparently, competing with its business ...

Viking Therapeutics VKTX announced that it has initiated the phase III VANQUISH program, evaluating the subcutaneous (SC) ...